Published in J Biol Chem on December 01, 2000
DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci U S A (2001) 2.16
Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol (2010) 1.73
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol (2009) 1.42
P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J (2008) 1.38
Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J (2001) 1.32
A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol (2006) 1.24
The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr (2011) 1.11
Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol (2006) 1.10
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol (2002) 1.04
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol (2001) 1.00
Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol (2003) 1.00
Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol (2001) 0.95
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease. J Cell Commun Signal (2010) 0.95
Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts. J Invest Dermatol (2008) 0.94
Connective tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue Repair (2012) 0.91
Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression. Biochem J (2002) 0.89
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer (2010) 0.88
SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton. Development (2012) 0.84
Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). Mol Pathol (2001) 0.81
Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells. BMC Cell Biol (2010) 0.79
Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells. Exp Mol Med (2009) 0.76
Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension. Exp Ther Med (2016) 0.75
Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress. J Cell Commun Signal (2012) 0.75
Evidence that stilbene synthases have developed from chalcone synthases several times in the course of evolution. J Mol Evol (1994) 1.44
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J Am Soc Nephrol (2001) 1.22
Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol (1998) 1.04
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation (2001) 1.04
Arginase of Agrobacterium Ti plasmid C58. DNA sequence, properties, and comparison with eucaryotic enzymes. Eur J Biochem (1989) 1.04
Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem (1994) 1.04
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol (2001) 1.00
Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum (2001) 1.00
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Effects of glucocorticoids on the TPA-induced monocytic differentiation. J Leukoc Biol (1992) 0.97
Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung. Am J Pathol (2000) 0.95
Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension (1998) 0.93
Purification of human leukotriene C4 synthase. Proc Natl Acad Sci U S A (1992) 0.93
Magnetic resonance imaging of coronary arteries and heart valves in a living mouse: techniques and preliminary results. J Magn Reson (2000) 0.90
An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J Am Soc Nephrol (2001) 0.90
Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Biochem Pharmacol (1990) 0.89
Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937. Biochim Biophys Acta (1990) 0.89
Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int (2006) 0.87
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant (1999) 0.86
Cytosolic phospholipase A2 from human monocytic cells: characterization of substrate specificity and Ca(2+)-dependent membrane association. Biochem J (1993) 0.84
Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J Neuroimmunol (1998) 0.84
Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int (1997) 0.83
Myocardial Na+ content after infarction during scar development. MAGMA (1998) 0.83
Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association. Biochem J (1991) 0.82
Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J Neurochem (2001) 0.82
Factors influencing metabolic rate in naked mole-rats (Heterocephalus glaber). Physiol Behav (1999) 0.82
Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. Kidney Int (1994) 0.81
Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett (1993) 0.81
Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene. Exp Cell Res (1996) 0.80
Alterations in glycosylation and lectin pattern during phorbol ester-induced differentiation of U937 cells. Cancer Res (1990) 0.79
Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Inflamm Res (2000) 0.79
Regulation of prostaglandin synthesis in Madin Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Biochim Biophys Acta (1996) 0.79
Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells. Biochem Pharmacol (1996) 0.78
[Clinically isolated syndrome]. Nervenarzt (2013) 0.78
Differential effect of dexamethasone on the regulation of phospholipase A2 and prostanoid synthesis in undifferentiated and phorbolester-differentiated U937 cells. J Cell Biochem (1989) 0.77
Monocytic-endothelial cell interaction: regulation of prostanoid synthesis in human coculture. J Leukoc Biol (1997) 0.77
Modulation of phospholipase D stimulation in c-src transfected mesangial cells. J Lipid Mediat Cell Signal (1997) 0.77
Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells. Cytokine (1997) 0.77
[Modern visualization of the liver with MRT. Current trends and future perspectives]. Radiologe (2004) 0.75
Phospholipase A2 activity in T-lymphocytes. FEBS Lett (1986) 0.75
Three-dimensional (13)C-spectroscopic imaging in the isolated infarcted rat heart. J Magn Reson (2000) 0.75
Cox-2 and osteopontin in cocultured platelets and mesangial cells: role of glucocorticoids. Kidney Int (2000) 0.75